These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Vaccination options for pregnant women during the Omicron period. He J; Wei Z; Leng T; Bao J; Gao X; Chen F J Reprod Immunol; 2023 Mar; 156():103798. PubMed ID: 36640675 [TBL] [Abstract][Full Text] [Related]
44. Estimated BNT162b2 Vaccine Effectiveness Against Infection With Delta and Omicron Variants Among US Children 5 to 11 Years of Age. Khan FL; Nguyen JL; Singh TG; Puzniak LA; Wiemken TL; Schrecker JP; Taitel MS; Zamparo JM; Jodar L; McLaughlin JM JAMA Netw Open; 2022 Dec; 5(12):e2246915. PubMed ID: 36515946 [TBL] [Abstract][Full Text] [Related]
45. Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States. Schrag SJ; Verani JR; Dixon BE; Page JM; Butterfield KA; Gaglani M; Vazquez-Benitez G; Zerbo O; Natarajan K; Ong TC; Lazariu V; Rao S; Beaver R; Ellington SR; Klein NP; Irving SA; Grannis SJ; Kiduko S; Barron MA; Midturi J; Dickerson M; Lewis N; Stockwell MS; Stenehjem E; Fadel WF; Link-Gelles R; Murthy K; Goddard K; Grisel N; Valvi NR; Fireman B; Arndorfer J; Konatham D; Ball S; Thompson MG; Naleway AL JAMA Netw Open; 2022 Sep; 5(9):e2233273. PubMed ID: 36156146 [TBL] [Abstract][Full Text] [Related]
47. COVID-19: Impact of Original, Gamma, Delta, and Omicron Variants of SARS-CoV-2 in Vaccinated and Unvaccinated Pregnant and Postpartum Women. Serra FE; Rosa Junior ER; de Rossi P; Francisco RPV; Rodrigues AS Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560582 [TBL] [Abstract][Full Text] [Related]
51. Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: A cohort study and ecological analysis. Català M; Coma E; Alonso S; Andrés C; Blanco I; Antón A; Bordoy AE; Cardona PJ; Fina F; Martró E; Medina M; Mora N; Saludes V; Prats C; Prieto-Alhambra D; Alvarez-Lacalle E Front Public Health; 2022; 10():961030. PubMed ID: 36033822 [TBL] [Abstract][Full Text] [Related]
52. Severe COVID-19 during pregnancy in Sweden, Norway, and Denmark. Örtqvist AK; Magnus MC; Aabakke AJM; Urhoj SK; Vinkel Hansen A; Nybo Andersen AM; Krebs L; Pettersson K; Håberg SE; Stephansson O Acta Obstet Gynecol Scand; 2023 Jun; 102(6):681-689. PubMed ID: 36928990 [TBL] [Abstract][Full Text] [Related]
53. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022. Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225 [TBL] [Abstract][Full Text] [Related]
54. Reduced control of SARS-CoV-2 infection is associated with lower mucosal antibody responses in pregnant women. St Clair LA; Eldesouki RE; Sachithanandham J; Yin A; Fall A; Morris CP; Norton JM; Forman M; Abdullah O; Dhakal S; Barranta C; Golding H; Bersoff-Matcha SJ; Pilgrim-Grayson C; Berhane L; Cox AL; Burd I; Pekosz A; Mostafa HH; Klein EY; Klein SL medRxiv; 2023 Mar; ():. PubMed ID: 36993216 [TBL] [Abstract][Full Text] [Related]
55. Comparison of clinical features and perinatal outcomes between pre-variant and post-variant periods in pregnant women with SARS-CoV-2: analysis of 1935 cases. Sahin D; Tanacan A; Anuk AT; Sinaci S; Besimoglu B; Oluklu D; Hendem DU; Beser DM; Yildirim M; Sakcak B; Erol SA; Colakoglu Y; Ayhan SG; Turgut E; Unlu S; Canpolat FE; Izdes S; Turan S; Surel AA; Tekin OM Arch Gynecol Obstet; 2022 Dec; 306(6):1939-1948. PubMed ID: 35257193 [TBL] [Abstract][Full Text] [Related]
56. Comparison of Symptoms Associated With SARS-CoV-2 Variants Among Children in Canada. Sumner MW; Xie J; Zemek R; Winston K; Freire G; Burstein B; Kam A; Emsley J; Gravel J; Porter R; Sabhaney V; Mater A; Salvadori MI; Berthelot S; Beer D; Poonai N; Moffatt A; Wright B; Freedman SB; JAMA Netw Open; 2023 Mar; 6(3):e232328. PubMed ID: 36892839 [TBL] [Abstract][Full Text] [Related]
57. SARS-CoV-2 infection among patients with autoimmune rheumatic diseases; comparison between the Delta and Omicron waves in Israel. Bieber A; Brikman S; Novack L; Ayalon S; Abu-Shakra M; Zeller L; Mader R; Sagy I Semin Arthritis Rheum; 2023 Feb; 58():152129. PubMed ID: 36462304 [TBL] [Abstract][Full Text] [Related]
58. Comparison of risk factors for SARS-CoV-2 infection among healthcare workers during Omicron and Delta dominance periods in Japan. Li Y; Yamamoto S; Oshiro Y; Inamura N; Nemoto T; Horii K; Takeuchi JS; Mizoue T; Konishi M; Ozeki M; Sugiyama H; Sugiura W; Ohmagari N J Hosp Infect; 2023 Apr; 134():97-107. PubMed ID: 36805085 [TBL] [Abstract][Full Text] [Related]
59. Reduction in Chest CT Severity and Improved Hospital Outcomes in SARS-CoV-2 Omicron Compared with Delta Variant Infection. Tsakok MT; Watson RA; Saujani SJ; Kong M; Xie C; Peschl H; Wing L; MacLeod FK; Shine B; Talbot NP; Benamore RE; Eyre DW; Gleeson F Radiology; 2023 Jan; 306(1):261-269. PubMed ID: 35727150 [TBL] [Abstract][Full Text] [Related]
60. Pregnancy-related and Neonatal Outcomes during Omicron Variant-Dominant COVID-19 Pandemic among the Black-Dominant Population. Min DD; Min JH Am J Perinatol; 2024 Jul; ():. PubMed ID: 38889887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]